Literature DB >> 23090487

Mechanisms of mesenchymal stromal cell immunomodulation.

Karen English1.   

Abstract

Multipotent mesenchymal stromal cells (MSCs) have generated considerable interest in the fields of regenerative medicine, cell therapy and immune modulation. Over the past 5 years, the initial observations that MSCs could enhance regeneration and modulate immune responses have been significantly advanced and we now have a clearer picture of the effects that MSCs have on the immune system particularly in the context of inflammatory-mediated disorders. A number of mechanisms of action have been reported in MSC immunomodulation, which encompass the secretion of soluble factors, induction of anergy, apoptosis, regulatory T cells and tolerogenic dendritic cells. It is clear that MSCs modulate both innate and adaptive responses and evidence is now emerging that the local microenvironment is key in the activation or licensing of MSCs to become immunosuppressive. More recently, studies have suggested that MSCs have the capacity to sense their environment and have a role in pathogen clearance in conjunction with the resolution of insult or injury. This review focuses on the mechanisms of MSC immunomodulation discussing the multistep process of MSC localisation at sites of inflammation, the cross talk between MSCs and the local microenvironment as well as the subsequent mechanisms of action used to resolve inflammation.

Entities:  

Mesh:

Year:  2012        PMID: 23090487     DOI: 10.1038/icb.2012.56

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  204 in total

1.  Role of Suppressor of Cytokine Signaling 3 in the Immune Modulation of Mesenchymal Stromal Cells.

Authors:  Chen Yang; Chunquan Zheng; Hai Lin; Jing Li; Keqing Zhao
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

Review 2.  Mesenchymal stem cells as cellular vectors for pediatric neurological disorders.

Authors:  Donald G Phinney; Iryna A Isakova
Journal:  Brain Res       Date:  2014-05-22       Impact factor: 3.252

3.  Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway.

Authors:  Laura Y Lu; Florence Loi; Karthik Nathan; Tzu-Hua Lin; Jukka Pajarinen; Emmanuel Gibon; Akira Nabeshima; Luis Cordova; Eemeli Jämsen; Zhenyu Yao; Stuart B Goodman
Journal:  J Orthop Res       Date:  2017-03-13       Impact factor: 3.494

Review 4.  Extracellular Matrix Bioscaffolds as Immunomodulatory Biomaterials<sup/>.

Authors:  Jenna L Dziki; Luai Huleihel; Michelle E Scarritt; Stephen F Badylak
Journal:  Tissue Eng Part A       Date:  2017-05-19       Impact factor: 3.845

5.  Biomechanical Forces Promote Immune Regulatory Function of Bone Marrow Mesenchymal Stromal Cells.

Authors:  Miguel F Diaz; Abishek B Vaidya; Siobahn M Evans; Hyun J Lee; Benjamin M Aertker; Alexander J Alexander; Katherine M Price; Joyce A Ozuna; George P Liao; Kevin R Aroom; Hasen Xue; Liang Gu; Rui Omichi; Supinder Bedi; Scott D Olson; Charles S Cox; Pamela L Wenzel
Journal:  Stem Cells       Date:  2017-03-05       Impact factor: 6.277

6.  Distinct Immunoregulatory Mechanisms in Mesenchymal Stem Cells: Role of the Cytokine Environment.

Authors:  Vladimir Holan; Barbora Hermankova; Pavla Bohacova; Jan Kossl; Milada Chudickova; Michaela Hajkova; Magdalena Krulova; Alena Zajicova; Eliska Javorkova
Journal:  Stem Cell Rev Rep       Date:  2016-12       Impact factor: 5.739

7.  Effects of three-dimensional spheroid culture on equine mesenchymal stem cell plasticity.

Authors:  Mi Jeong Park; Jienny Lee; Jeong Su Byeon; Da-Un Jeong; Na-Yeon Gu; In-Soo Cho; Sang-Ho Cha
Journal:  Vet Res Commun       Date:  2018-05-02       Impact factor: 2.459

Review 8.  Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models.

Authors:  Matthew W Klinker; Cheng-Hong Wei
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

9.  Transplantation of Human Adipose Mesenchymal Stem Cells in Non-Immunosuppressed GRMD Dogs is a Safe Procedure.

Authors:  M V Pelatti; J P A Gomes; N M S Vieira; E Cangussu; V Landini; T Andrade; M Sartori; L Petrus; Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2016-08       Impact factor: 5.739

Review 10.  Therapy with stem cells in inflammatory bowel disease.

Authors:  María Del Pilar Martínez-Montiel; Gonzalo Jesús Gómez-Gómez; Ana Isabel Flores
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.